S2k guideline “Calculated parenteral initial treatment of bacterial infections in adults – update 2018”, 2(nd) updated version: Foreword

por Bodmann, Klaus-Friedrich, Grabein, Béatrice, Kresken, Michael
Publicado 2020

Clinical and economical improvements after introducing rapid identification of bacteria and early antibiotic susceptibility testing in sepsis and bloodstream infections. Results of...

por Wilke, Michael, Heinlein, Wolfgang, Stiefenhofer, Luis, Bodmann, Klaus-Friedrich
Publicado 2020

Calculated initial parenteral treatment of bacterial infections: Sepsis

por Bodmann, Klaus-Friedrich, Höhl, Rainer, Krüger, Wolfgang, Grabein, Beatrice, Graninger, Wolfgang
Publicado 2020

Calculated initial parenteral treatment of bacterial infections: Bacterial endocarditis

por Dohmen, Pascal M., Bodmann, Klaus Friedrich, Graninger, Wolfgang, Shah, Pramod, Thallhammer, Florian
Publicado 2020

Calculated parenteral initial treatment of bacterial infections: Introduction and antibiotics

por Bodmann, Klaus-Friedrich, Kresken, Michael, Grabein, Béatrice, Dohmen, Pascal M., Wilke, Michael
Publicado 2020

Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment – a health economic analysis using German DRG data

por Wilke, Michael, Worf, Kerstin, Preisendörfer, Birgit, Heinlein, Wolfgang, Kast, Tilman, Bodmann, Klaus-Friedrich
Publicado 2019

Calculated parenteral initial treatment of bacterial infections: Respiratory infections

por Ott, Sebastian R., Bodmann, Klaus-Friedrich, Grabein, Béatrice, Höffken, Gert, Kolditz, Martin, Lode, Hartmut, Pletz, Mathias W., Thalhammer, Florian
Publicado 2020